Connor, Clark & Lunn Investment Management (CC&L)’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,357
| Closed | -$529K | – | 1764 |
|
|
2024
Q1 | $529K | Buy |
13,357
+1,448
| +12% | +$57.4K | ﹤0.01% | 1089 |
|
|
2023
Q4 | $227K | Sell |
11,909
-33,566
| -74% | -$640K | ﹤0.01% | 1236 |
|
|
2023
Q3 | $521K | Sell |
45,475
-1,118
| -2% | -$12.8K | ﹤0.01% | 1002 |
|
|
2023
Q2 | $479K | Sell |
46,593
-7,644
| -14% | -$78.6K | ﹤0.01% | 993 |
|
|
2023
Q1 | $419K | Sell |
54,237
-4,071
| -7% | -$31.4K | ﹤0.01% | 932 |
|
|
2022
Q4 | $429K | Buy |
58,308
+802
| +1% | +$5.9K | ﹤0.01% | 906 |
|
|
2022
Q3 | $414K | Buy |
57,506
+7,317
| +15% | +$52.7K | ﹤0.01% | 857 |
|
|
2022
Q2 | $427K | Buy |
50,189
+21,873
| +77% | +$186K | ﹤0.01% | 817 |
|
|
2022
Q1 | $254K | Buy |
28,316
+9,290
| +49% | +$83.3K | ﹤0.01% | 908 |
|
|
2021
Q4 | $264K | Buy |
+19,026
| New | +$264K | ﹤0.01% | 914 |
|
|
2017
Q2 | – | Sell |
-14,450
| Closed | -$169K | – | 979 |
|
|
2017
Q1 | $169K | Buy |
+14,450
| New | +$169K | ﹤0.01% | 815 |
|